Physician
Warrenfield Medical Center, P.C.
Warrenfield Medical Center, P.C. was paid $2.69M by Medicaid between Jan 2018 and Dec 2024, across 77 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 31% of everything it billed.
33Billing provider infoWARRENFIELD MEDICAL CENTER, P.C.
DEARBORN, MI 48126
DEARBORN, MI 48126
33aNPI1912120338assigned 04/11/2007
33bProvider typeFamily Medicine Physician
28Total paid$2.69M
24GClaims171,512
24DCodes billed77
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Michigan
Rank by total paid#41 of 826
Median peer was paid$98K
This provider vs. median28×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,424 | $326K | |
| 2019 | 23,201 | $317K | |
| 2020 | 22,483 | $316K | |
| 2021 | 25,227 | $396K | |
| 2022 | 29,327 | $492K | |
| 2023 | 32,532 | $506K | |
| 2024incomplete | 22,318 | $335K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 31% | 9,984 | 9,466 | $831K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 12,257 | 11,437 | $727K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 10.0% | 2,831 | 2,819 | $269K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 8.0% | 2,475 | 2,466 | $214K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 4.9% | 1,245 | 1,223 | $132K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.1% | 2,202 | 2,133 | $83K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.9% | 7,482 | 7,076 | $77K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.2% | 1,939 | 1,798 | $58K |
| 36415 | Collection of venous blood by venipuncture | 1.3% | 12,640 | 11,993 | $35K |
| 90688 | <1% | 1,282 | 1,280 | $24K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,161 | 1,079 | $21K |
| G0008 | Administration of influenza virus vaccine | <1% | 1,764 | 1,761 | $17K |
65 more codes
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,007 | $17K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 1,877 | $17K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,348 | $16K |
| 93000 | <1% | 1,364 | $12K | |
| 82962 | <1% | 4,835 | $11K | |
| 81002 | <1% | 3,943 | $10K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 1,688 | $9K |
| 99000 | <1% | 1,425 | $9K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 244 | $8K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 108 | $7K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 377 | $7K |
| 99385 | <1% | 67 | $7K | |
| 81025 | <1% | 840 | $6K | |
| 0011A | <1% | 219 | $5K | |
| 99490 | Ccm add 20min | <1% | 272 | $5K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 42 | $5K |
| 0012A | <1% | 183 | $5K | |
| 90658 | <1% | 325 | $5K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 191 | $4K |
| 0064A | <1% | 139 | $3K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 2,308 | $3K |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 619 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,449 | $3K |
| 80061 | Lipid panel | <1% | 177 | $2K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 38 | $2K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 29 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 188 | $2K |
| 73560 | <1% | 77 | $1K | |
| 99406 | <1% | 191 | $1K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 148 | $1K |
| 91322 | <1% | 12 | $1K | |
| 83735 | <1% | 169 | $1K | |
| 90686 | <1% | 52 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 100 | $861.41 |
| 72100 | <1% | 42 | $837.54 | |
| 76770 | <1% | 14 | $812.70 | |
| 90480 | <1% | 27 | $683.84 | |
| 83014 | <1% | 200 | $642.08 | |
| 0004A | <1% | 31 | $613.56 | |
| 0001A | <1% | 16 | $542.28 | |
| 0003A | <1% | 14 | $534.20 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 535 | $521.28 |
| 0013A | <1% | 13 | $462.80 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 265 | $434.82 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 44 | $417.25 |
| 84460 | <1% | 68 | $372.47 | |
| 87807 | <1% | 43 | $269.63 | |
| 86580 | <1% | 44 | $228.33 | |
| 90653 | <1% | 13 | $173.49 | |
| 99442 | <1% | 12 | $123.60 | |
| Q2035 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | <1% | 14 | $3.65 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 14 | $0.26 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 5,868 | $0.00 |
| 3079F | 0% | 9,174 | $0.00 | |
| 3080F | 0% | 5,127 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 2,961 | $0.00 |
| G8432 | Depression screening not documented, reason not given | 0% | 4,447 | $0.00 |
| 3075F | 0% | 3,887 | $0.00 | |
| 3044F | 0% | 318 | $0.00 | |
| 3074F | 0% | 16,678 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 22,423 | $0.00 |
| 3078F | 0% | 9,978 | $0.00 | |
| 3077F | 0% | 3,583 | $0.00 | |
| G8511 | Screening for depression documented as positive, follow-up plan not documented, reason not given | 0% | 301 | $0.00 |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 45 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialOBEID, ERFAN (MEDICAL DIRECTOR)